Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Outsourcing

Wacker acquires plasmid DNA expert Genopis

by Rick Mullin
February 20, 2021 | A version of this story appeared in Volume 99, Issue 6

 

Expanding its contract manufacturing business, Wacker Chemie will acquire Genopis, a San Diego–based expert in plasmid DNA (pDNA) technology, from Helixmith for $39 million. Genopis operates a 500 L pDNA fermentation line and is building a small-scale fermentation facility. “The acquisition allows us to establish a local presence in the large US market for biologics,” Wacker CEO Rudolf Staudigl says in a press release. Wacker says it will work with Helixmith to produce a pDNA therapy for diabetic peripheral neuropathy.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.